Lastly, DPP-4 has been reported to possess a deleterious role and potential to be used as a biomarker in respiratory diseases, such as lung cancer, asthma, and chronic obstructive pulmonary disease (COPD) [88,89,90]. The gene discussed is DPP4; the disease is asthma.